NYSE:ENZ

Enzo Biochem News Headlines

$3.21
+0.05 (+1.58 %)
(As of 04/21/2021 02:31 PM ET)
Add
Compare
Today's Range
$3.15
Now: $3.21
$3.21
50-Day Range
$2.75
MA: $3.31
$4.08
52-Week Range
$1.80
Now: $3.21
$4.85
Volume3,378 shs
Average Volume1.14 million shs
Market Capitalization$154.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89

Headlines

Enzo Biochem (NYSE ENZ) News Headlines Today

SourceHeadline
Enzos Universal AMPICOLLECT(TM) Used on GENFLEX(R) Molecular Platform Cleared for Distribution by FDA Under Emergency Use AuthorizationEnzo's Universal AMPICOLLECT(TM) Used on GENFLEX(R) Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
marketwatch.com - April 21 at 12:52 PM
BRIEF-Enzo’s AMPICOLLECT Cleared for Distribution by FDA Under Emergency Use AuthorizationBRIEF-Enzo’s AMPICOLLECT Cleared for Distribution by FDA Under Emergency Use Authorization
msn.com - April 21 at 12:52 PM
Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use AuthorizationEnzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
finance.yahoo.com - April 21 at 12:52 PM
Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Drops By 24.7%Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Drops By 24.7%
americanbankingnews.com - April 18 at 6:16 PM
Biomarkers Market Trends, Share, Research Report Study, Regional and Industry Analysis, Forecast to 2027Biomarkers Market Trends, Share, Research Report Study, Regional and Industry Analysis, Forecast to 2027
marketwatch.com - April 14 at 10:02 AM
Epoxomicin Market Size Research Report 2021 by Manufacturers, Regions, Type, Application, Sales, Revenue, Gross Margin and Forecast to 2027Epoxomicin Market Size Research Report 2021 by Manufacturers, Regions, Type, Application, Sales, Revenue, Gross Margin and Forecast to 2027
marketwatch.com - April 9 at 7:18 AM
Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200 Day Moving Average of $2.62Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200 Day Moving Average of $2.62
americanbankingnews.com - April 7 at 2:02 AM
Enzo Biochems(NYSE:ENZ) Share Price Is Down 41% Over The Past Three Years.Enzo Biochem's(NYSE:ENZ) Share Price Is Down 41% Over The Past Three Years.
finance.yahoo.com - March 31 at 1:09 PM
Enzo Biochem (NYSE:ENZ) versus AnPac Bio-Medical Science (NASDAQ:ANPC) Financial ContrastEnzo Biochem (NYSE:ENZ) versus AnPac Bio-Medical Science (NASDAQ:ANPC) Financial Contrast
americanbankingnews.com - March 28 at 2:40 AM
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc.180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc.
finance.yahoo.com - March 22 at 12:22 PM
ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS LIFE SCIENCES & MEDTECH INVESTOR FORUMENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
finance.yahoo.com - March 17 at 6:20 PM
Harbert Discovery Fund Responds to Enzo Biochem, Inc.’s Recent Strategic AnnouncementsHarbert Discovery Fund Responds to Enzo Biochem, Inc.’s Recent Strategic Announcements
finance.yahoo.com - March 16 at 5:04 PM
Enzo Biochem Blasts Higher as Revenue Jumps 62%Enzo Biochem Blasts Higher as Revenue Jumps 62%
finance.yahoo.com - March 16 at 5:04 PM
COVID-19: Make Sure The Test Covers New Variants, Experts SayCOVID-19: Make Sure The Test Covers New Variants, Experts Say
msn.com - March 5 at 3:12 PM
Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences ConferenceEnzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 4 at 8:52 AM
Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 VariantsEnzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
finance.yahoo.com - March 2 at 9:35 AM
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
finance.yahoo.com - March 1 at 6:31 PM
Global Clinical Biomarkers Market 2020 Future Estimations with Top Key Players, Production Development and Opportunities to 2025Global Clinical Biomarkers Market 2020 Future Estimations with Top Key Players, Production Development and Opportunities to 2025
marketwatch.com - March 1 at 12:21 AM
Enzo Biochem’s CEO urged to resign by top investorEnzo Biochem’s CEO urged to resign by top investor
seekingalpha.com - February 27 at 11:47 PM
Biomarker Market Report 2021 Industry Size, Market Status, Influencing Factors, Competition, SWOT Analysis, Outlook and 2027 ForecastBiomarker Market Report 2021 Industry Size, Market Status, Influencing Factors, Competition, SWOT Analysis, Outlook and 2027 Forecast
marketwatch.com - February 23 at 9:56 AM
Nutlin-3 Market Share, Application Analysis, Regional Outlook, Competitive Strategies, Key Players & Forecast up to 2026Nutlin-3 Market Share, Application Analysis, Regional Outlook, Competitive Strategies, Key Players & Forecast up to 2026
marketwatch.com - February 17 at 7:41 AM
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target SclerostinEnzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
finance.yahoo.com - February 3 at 9:44 AM
Is Enzo Biochem, Inc. (NYSE:ENZ) Popular Amongst Insiders?Is Enzo Biochem, Inc. (NYSE:ENZ) Popular Amongst Insiders?
finance.yahoo.com - January 30 at 1:40 PM
Enzo Biochem and Tenneco See Activist ActionEnzo Biochem and Tenneco See Activist Action
finance.yahoo.com - January 22 at 10:18 PM
ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENTENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
markets.businessinsider.com - January 14 at 12:09 AM
ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS  10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENTENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
finance.yahoo.com - January 5 at 11:10 AM
Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc.Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc.
benzinga.com - January 4 at 5:38 PM
BUZZ-U.S. STOCKS ON THE MOVE-Ocugen Inc, Enzo Biochem, Kaixin Auto, oil stocksBUZZ-U.S. STOCKS ON THE MOVE-Ocugen Inc, Enzo Biochem, Kaixin Auto, oil stocks
nasdaq.com - January 4 at 12:35 PM
ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
finance.yahoo.com - January 4 at 7:35 AM
Enzo Biochem Issues Response Related To ISS View Of Compensation For Chair, CEOEnzo Biochem Issues Response Related To ISS View Of Compensation For Chair, CEO
benzinga.com - December 29 at 7:54 PM
Enzo Biochem 13D Shows 5.8% Stake From Roumell Asset Management, LLC; Roumell Criticizes Common Stock BonusesEnzo Biochem 13D Shows 5.8% Stake From Roumell Asset Management, LLC; Roumell Criticizes Common Stock Bonuses
benzinga.com - December 29 at 7:54 PM
Biomarkers Market 2020 Current and Future Trend Scenario Explored In New Latest Research ReportBiomarkers Market 2020 Current and Future Trend Scenario Explored In New Latest Research Report
marketwatch.com - December 23 at 1:53 AM
Enzo Biochem: Betting On The Activists NowEnzo Biochem: Betting On The Activists Now
seekingalpha.com - December 16 at 8:46 AM
Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment EnvironmentEnzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
finance.yahoo.com - December 15 at 8:43 AM
Is ENZ A Good Stock To Buy Now?Is ENZ A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 8:31 PM
Shareholders at Embattled Enzo Biochem Want AnswersShareholders at Embattled Enzo Biochem Want Answers
finance.yahoo.com - December 9 at 6:26 PM
Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business UpdateEnzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
finance.yahoo.com - December 9 at 6:26 PM
Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
finance.yahoo.com - December 2 at 1:58 PM
Health Check: How Prudently Does Enzo Biochem (NYSE:ENZ) Use Debt?Health Check: How Prudently Does Enzo Biochem (NYSE:ENZ) Use Debt?
finance.yahoo.com - December 1 at 9:19 AM
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORSENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS
finance.yahoo.com - November 25 at 12:45 PM
Harbert Discovery Fund Issues Letter to Enzo Biochem Board of DirectorsHarbert Discovery Fund Issues Letter to Enzo Biochem Board of Directors
finance.yahoo.com - November 18 at 3:31 PM
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORSENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
markets.businessinsider.com - November 18 at 8:40 AM
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD,  TO ITS BOARD OF DIRECTORSENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
finance.yahoo.com - November 18 at 8:40 AM
ENZO PROVIDES CORPORATE BUSINESS UPDATEENZO PROVIDES CORPORATE BUSINESS UPDATE
finance.yahoo.com - November 17 at 9:33 AM
ENZO LAUNCHES PORTABLE MICROPLATE READER FOR USE WITH ITS ELISA AND ASSAY KITS TO SIMPLIFY LABORATORY WORKFLOWENZO LAUNCHES PORTABLE MICROPLATE READER FOR USE WITH ITS ELISA AND ASSAY KITS TO SIMPLIFY LABORATORY WORKFLOW
finance.yahoo.com - November 5 at 8:20 AM
ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTSENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS
finance.yahoo.com - October 27 at 9:52 AM
ENZO BIOCHEM. INC. DL-,01 (EZB.MU)ENZO BIOCHEM. INC. DL-,01 (EZB.MU)
ca.finance.yahoo.com - October 16 at 6:25 AM
ENZO BIOCHEM INC. Registered Sh (EZB.SG)ENZO BIOCHEM INC. Registered Sh (EZB.SG)
in.finance.yahoo.com - October 14 at 7:43 PM
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochems Q4, Codiak DebutsThe Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
msn.com - October 14 at 9:41 AM
Enzo Biochem reports FQ4 resultsEnzo Biochem reports FQ4 results
seekingalpha.com - October 13 at 8:42 PM
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.